Related Experiment Video
Updated: May 27, 2026

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage
Published on: May 10, 2022
Recommendations on the statistical analysis of the Comet assay
Jonathan Bright1, Mike Aylott, Simon Bate
1Discovery Statistics, AstraZeneca R&D, Macclesfield, Cheshire, UK. jonathan.bright@astrazeneca.com
Abstract:
In 2010, the Statisticians in the Pharmaceutical Industry (PSI) Toxicology Special Interest Group met to discuss the design and analysis of the Comet assay. The Comet assay is one potential component of the package of safety studies required by regulatory bodies. As these studies usually involve a three-way nested experimental design and as the distribution of the measured response is usually either lognormal or lognormal plus a point mass at zero, the analysis is not straightforward. This has led to many different types of analysis being proposed in the literature, with several different methods applied within the pharmaceutical industry itself. This article summarises the PSI Toxicology Group's discussions and recommendations around these issues.

